Targeted pill tested against hard-to-treat cancers
Disease control
Terminated
This study tested an oral medication called ART0380 for people with advanced or metastatic solid tumors that have specific weaknesses in their DNA repair system. It aimed to see if the drug could shrink tumors and was safe. The trial was designed for 36 participants, including th…
Phase: PHASE2 • Sponsor: Artios Pharma Ltd • Aim: Disease control
Last updated Mar 02, 2026 15:26 UTC